Knott David M Jr Mereo Biopharma Group PLC Transaction History
Knott David M Jr
- $160 Million
- Q1 2025
A detailed history of Knott David M Jr transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Knott David M Jr holds 319,337 shares of MREO stock, worth $533,292. This represents 0.45% of its overall portfolio holdings.
Number of Shares
319,337
Previous 331,000
3.52%
Holding current value
$533,292
Previous $1.16 Million
38.0%
% of portfolio
0.45%
Previous 0.67%
Shares
4 transactions
Others Institutions Holding MREO
# of Institutions
99Shares Held
113MCall Options Held
1MPut Options Held
668K-
Janus Henderson Group PLC London, X022.7MShares$38 Million0.03% of portfolio
-
Rubric Capital Management LP New York, NY15.3MShares$25.6 Million0.99% of portfolio
-
Mangrove Partners New York, NY8.64MShares$14.4 Million3.05% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA7.82MShares$13.1 Million1.11% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY6.71MShares$11.2 Million0.38% of portfolio
About Mereo Biopharma Group plc
- Ticker MREO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,986,000
- Market Cap $209M
- Description
- Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...